PT  - JOURNAL ARTICLE
AU  - Rajapaksha, R. M. Nayani Umesha
AU  - Wijesinghe, Millawage Supun Dilara
AU  - Thomas, Toms K.
AU  - Jayasooriya, Sujith P.
AU  - Gunawardana, B. M. W. Indika
AU  - Weerasinghe, W. M. Prasad Chathuranga
AU  - Bhakta, Shalini
AU  - Assefa, Yibeltal
TI  - Predictive Analysis of COVID-19 Spread in Sri Lanka using an Adaptive Compartmental Model: Susceptible-Exposed-Infected-Recovered-Dead (SEIRD) Model
AID  - 10.1101/2021.08.09.21261819
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2021.08.09.21261819
4099  - http://medrxiv.org/content/early/2022/08/23/2021.08.09.21261819.short
4100  - http://medrxiv.org/content/early/2022/08/23/2021.08.09.21261819.full
AB  - Novel Corona Virus (COVID-19) is still spreading throughout the world despite various degrees of movement restrictions and the availability of multiple safe and effective vaccines. Modelling in predicting the spread of an epidemic is important for health planning and policies. This study aimed to apply a dynamic Susceptible-Exposed-Infected-Recovered-Deaths (SEIRD) model and simulated it under a range of epidemic conditions using python programme language. The predictions were based on different scenarios from without any preventive measures to several different preventive measures under R0 of 4. The model shows that more weight to personal protection can halt the spread of transmission followed by the closure of public places and interprovincial movement restriction. Results after simulating various scenarios indicate that disregarding personal protective measures can have devastating effects on the local population. Strict adherence, maintaining and monitoring of self-preventive measures are vital towards minimizing the death toll from COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementWe did not receive any funding from funding agencies for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research design and methodology used only anonymized data sets. This entails that no ethical approval is required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPublicly available data was taken from the dash board of HPB, Ministry of Health